Empagliflozin Attenuates Arrhythmias in an iPSC-Based Model of Hypertrophic Cardiomyopathy

被引：0

作者：

Ataam, Jennifer Arthur

Belbachir, Nadjet ^{[2
,3
]}

Perea-Gil, Isaac ^{[1
,2
]}

Termglinchan, Vittavat ^{[1
,2
]}

Vadgama, Nirmal ^{[1
,2
]}

Garg, Priyanka ^{[2
,3
]}

Ramchandani, Rohin ^{[1
,2
]}

Gavidia, Alexandra A. ^{[1
,2
]}

Roura, Santiago ^{[4
,5
,6
]}

Galvez-Monton, Carolina ^{[4
,5
]}

Wu, Joseph C. ^{[2
,3
]}

Bayes-Genis, Antoni ^{[4
,5
,7
,8
]}

Karakikes, Ioannis ^{[1
,2
]}

机构：

[1] Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA USA

[2] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA USA

[3] Stanford Univ, Dept Med, Sch Med, Stanford, CA USA

[4] Germans Trias i Pujol Hlth Sci Res Inst, Res Program, Insuficiencia Cardiaca Regeneracio Cardiaca, Badalona, Spain

[5] Inst Salud Carlos III, Ctr Investiogac Red Cardiovasc Cardiovasc, Madrid, Spain

[6] Cent Univ Catalonia, Univ Vic, Fac Med, Vic, Spain

[7] Germans Trias i Pujol Univ Hosp, Cardiol Serv, Badalona, Spain

[8] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain

来源：

CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2024年 / 17卷 / 03期

关键词：

arrhythmias; cardiac; cardiomyopathy; hypertrophic; drug repositioning; genetics; myocytes; sodium-glucose transporter 2 inhibitors;

D O I：

10.1161/CIRCGEN.123.004526

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：268 / 270

页数：3

共 50 条

[1] iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy
Escriba, Ruben
Larranaga-Moreira, Jose M.
Richaud-Patin, Yvonne
Pourchet, Lea
Lazis, Ioannis
Jimenez-Delgado, Senda
Morillas-Garcia, Alba
Ortiz-Genga, Martin
Ochoa, Juan Pablo
Carreras, David
Perez, Guillermo Javier
de la Pompa, Jose Luis
Brugada, Ramon
Monserrat, Lorenzo
Barriales-Villa, Roberto
Raya, Angel
CIRCULATION RESEARCH, 2023, 133 (02) : 108 - 119
[2] Genetic Correction of Phospholamban Mutation in an iPSC-Based Disease Model of Familial Dilated Cardiomyopathy
Nonnenmacher, Mathieu E.
Karakikes, Ioannis
Stillitano, Francesca
Weber, Thomas
Hajjar, Roger J.
MOLECULAR THERAPY, 2014, 22 : S193 - S193
[3] Generation of iPSC-based cardiomyocytes for investigating mechanisms of dilated cardiomyopathy
Streckfuss-Boemeke, K.
Tiburcy, M.
Fomin, A.
Fischer, C.
Perrot, A.
Oezcelik, C.
Sossalla, S.
Linke, W. A.
Zimmermann, W.
Hasenfuss, G.
Guan, K.
ACTA PHYSIOLOGICA, 2015, 213 : 23 - 24
[4] Arrhythmias in hypertrophic cardiomyopathy
Kuck, KH
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (10): : 2706 - 2713
[5] ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
KRELHAUS, W
KUHN, H
SEIPEL, L
LOOGEN, F
ZEITSCHRIFT FUR KARDIOLOGIE, 1977, 66 (09): : 530 - 530
[6] DEVELOPMENT OF AN IPSC-BASED MODEL FOR THE STUDY OF PERIPHERAL NEUROPATHIES
Imran, Saima
Bayraktar, Erva
Caballe, Rafael Balada
Crispino, Giulia
Pellizzon, Angela
Marino, Saralea
Rakovic, Aleksandar
Andrews, Peter
Bortolozzi, Mario
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S7 - S7
[7] Ventricular arrhythmias and remodeling in a mouse model of hypertrophic cardiomyopathy
Flenner, F.
Kuepker, N.
Friedrich, F. W.
Jungen, C.
Kruse, M.
Soehren, K. D.
Meyer, C.
Eschenhagen, T.
Christ, T.
Carrier, L.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 120 : 30 - 31
[8] A Human iPSC-Based Model of the Complement System in CNS Cells
Demers, Matthew
D'Aiuto, Leonardo
Wood, Joel
Nimgaonkar, Vishwajit
Zheng, Wenxiao
BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S135 - S135
[9] Arrhythmias of primary hypertrophic cardiomyopathy
Babuty, D
Fauchier, L
Nguyen, D
Giraudeau, C
Marie, O
Fauchier, JP
Cosnay, P
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2003, 96 : 7 - 15
[10] MANAGEMENT OF ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
STEWART, JT
MCKENNA, WJ
CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (01) : 95 - 99

← 1 2 3 4 5 →